Cargando…
COVID-19 Vaccines for HIV-Infected Patients
Nearly 40 years have passed since the initial cases of infection with the human mmunodeficiency virus (HIV) were identified as a new disease entity and the cause of acquired immunodeficiency disease (AIDS). This virus, unlike any other, is capable of causing severe suppression of our adaptive immune...
Autores principales: | Plummer, Maria M., Pavia, Charles S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540182/ https://www.ncbi.nlm.nih.gov/pubmed/34696319 http://dx.doi.org/10.3390/v13101890 |
Ejemplares similares
-
COVID-19 vaccines for high risk and immunocompromised patients
por: Pavia, Charles S., et al.
Publicado: (2022) -
The evolution of rapid antigen detection systems and their application for COVID-19 and other serious respiratory infectious diseases
por: S. Pavia, Charles, et al.
Publicado: (2021) -
Impact of the COVID-19 pandemic on Easter
por: Pavia, Charles S., et al.
Publicado: (2021) -
Pasteur, Vaccines, and the Refusal to Become Fully Vaccinated in the Midst of the COVID-19 Pandemic
por: Pavia, Charles S.
Publicado: (2022) -
Hesitancy to get vaccinated against COVID-19 and how it might be overcome
por: Pavia, Charles S.
Publicado: (2022)